| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3401442 | Enfermedades Infecciosas y Microbiología Clínica | 2012 | 8 Pages |
Abstract
Many antibiotics are easily removed by continuous renal replacement therapies (CRRT) leading to a high risk of under dosing and therapeutic failure or resistance breakthrough. The objective of this review is to assess the clinical evidence on the pharmacokinetics and dosage recommendations of the main antibiotic groups used in MRSA treatment in patients treated with CRRT.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Esther Carcelero, Dolors Soy,